We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

EKF Diagnostics Holdings plc (EKF) Ordinary 1p

Sell:24.10p Buy:25.90p 0 Change: 2.60p (10.83%)
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:24.10p
Buy:25.90p
Change: 2.60p (10.83%)
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:24.10p
Buy:25.90p
Change: 2.60p (10.83%)
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

EKF Diagnostics Holdings plc is a United Kingdom-based diagnostics company. The Company is engaged in point-of-care testing, central laboratory tests, enzyme manufacturing and the provision of contract manufacturing services to the healthcare industry. Its principal activity is the development, manufacture and supply of products into the in-vitro diagnostics marketplace. Its point of care analyzers is designed for use within doctors' surgeries, clinics, blood banks and hospital and private laboratories to provide results. Its life sciences specialize in producing enzymes and contracted custom products for use in medical diagnostics, pharmaceuticals and industry. Its life science facilities are based in two locations in Indiana, United States. Its central laboratory division manufactures a spectrum of reagents for use in hospital laboratories. Its contract manufacturing business provides specialized services to the diagnostics and healthcare industries for the production of custom kits.

Contact details

Address:
Avon HSE, 19 Stanwell Road
PENARTH
CF64 2EZ
United Kingdom
Telephone:
+44 (029) 20710570
Website:
https://www.ekfdiagnostics.com/

Important dates

Future events
There are no future events available.
Past events
Interim results 17 September 2024 17/09/24
Trading Announcement 24 July 2024 24/07/24
AGM 17 May 2024 17/05/24
Trading Announcement 14 May 2024 14/05/24
AGM 14 May 2024 14/05/24
Annual report 22 April 2024 22/04/24
Final results 20 March 2024 20/03/24
Trading Announcement 29 January 2024 29/01/24

General stock information

EPIC:
EKF
ISIN:
GB0031509804
Market cap:
£120.69 million
Shares in issue:
453.73 million
Sector:
Health Care Equipment & Services
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Julian Baines
    Executive Chairman of the Board
  • Stephen Young
    Chief Financial Officer, Executive Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.